News Roivant’s Anti-inflammatory Drug Shows Promise in Mid-stage Study by Medscape • 2024/04/02 • 0 Comments Roivant Sciences' experimental drug to treat non-infectious uveitis helped reduce symptoms of the inflammatory eye disease in a mid-stage study, sending the biotech firm's... Reuters Health Information Full Story →